Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic stroke.
Lemmerman LR, Balch MHH, Moore JT, Alzate-Correa D, Rincon-Benavides MA, Salazar-Puerta A, Gnyawali S, Harris HN, Lawrence W, Ortega-Pineda L, Wilch L, Risser IB, Maxwell AJ, Duarte-Sanmiguel S, Dodd D, Guio-Vega GP, McTigue DM, Arnold WD, Nimjee SM, Sen CK, Khanna S, Rink C, Higuita-Castro N, Gallego-Perez D.
Lemmerman LR, et al. Among authors: nimjee sm.
Sci Adv. 2021 Mar 19;7(12):eabd4735. doi: 10.1126/sciadv.abd4735. Print 2021 Mar.
Sci Adv. 2021.
PMID: 33741587
Free PMC article.